Department Of Cardiovascular Medicine 1
1. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
2. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
3. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
4. 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models
5. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
6. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019
7. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
8. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
9. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
10. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
11. The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
12. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
13. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
14. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
15. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
16. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
17. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
18. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
19. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
20. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
21. Association of 24-h central hemodynamics and stiffness with cardiovascular events and all-cause mortality. The VASOTENS Registry
22. Safety, Efficacy and Long-Term Outcomes of Patients Treated with the Occlutech Paravalvular Leak Device for Significant Paravalvular Regurgitation
23. Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)
24. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
25. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
26. Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC
27. Mapping routine measles vaccination in low- and middle-income countries
28. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
29. Insights into the European heart failure epidemiology
30. The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations
31. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
32. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
33. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
34. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
35. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
36. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus
37. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
38. Global burden of metabolic diseases, 1990–2021
39. Global burden of metabolic diseases, 1990–2021
40. Global burden of metabolic diseases, 1990–2021
41. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
42. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
43. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
44. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
45. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
46. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
47. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
48. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1